Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.

Advancements in biotechnology and manufacturing techniques have enabled the large-scale production of AAV vectors, meeting the growing demand for clinical and commercial applications. Regulatory ...

adeno-associated virus (AAV)–based vectors designed to evade the body’s anti-AAV immune response. The company’s proprietary EVADER vectors, which consist of enveloped AAV particles ...

Recombinant adeno-associated virus (AAV) and lentiviral vectors (LV) are vehicles for direct delivery of therapeutic genes ... The VirusGEN® AAV and LV Transfection Kits push the limits of high-titer ...

In a recently published study, researchers at the Institute of Molecular and Clinical Ophthalmology Basel and collaborators proposed a novel dual AAV vector system to deliver a split-intein adenine ...

Axovia’s lead program AXV101 is an adeno-associated virus (AAV9)-based investigational gene therapy that aims to slow down or ...

Adeno-associated viral (AAV) vectors in particular have high transduction rates and reduced toxicity concerns compared to other viral vectors. However, these delivery vehicles present some application ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...

Correctly measuring AAV vectors, as they are called ... the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), and the U.S. Pharmacopeia (USP) recruited six industry ...

Gene therapy commonly uses viral vectors to integrate corrective genetic sequences into cellular genomes ... they must be produced in sufficient quantities to meet clinical demand. However, setting up ...

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications ...